Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer

NCT00429299 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Breast

Interventions

DRUG: lapatinib
BIOLOGICAL: trastuzumab
DRUG: paclitaxel
DRUG: fluorouracil
DRUG: epidoxorubicin
DRUG: cyclophosphamide

Sponsor

GlaxoSmithKline